ATE419380T1 - Bestimmung des kollagen genotyps - Google Patents

Bestimmung des kollagen genotyps

Info

Publication number
ATE419380T1
ATE419380T1 AT97905309T AT97905309T ATE419380T1 AT E419380 T1 ATE419380 T1 AT E419380T1 AT 97905309 T AT97905309 T AT 97905309T AT 97905309 T AT97905309 T AT 97905309T AT E419380 T1 ATE419380 T1 AT E419380T1
Authority
AT
Austria
Prior art keywords
genotype
collagen
determination
polymorphism
predisposition
Prior art date
Application number
AT97905309T
Other languages
English (en)
Inventor
Stuart Ralston
Struan Frederick Grant
Original Assignee
Sequenom Gemini Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sequenom Gemini Ltd filed Critical Sequenom Gemini Ltd
Application granted granted Critical
Publication of ATE419380T1 publication Critical patent/ATE419380T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pretreatment Of Seeds And Plants (AREA)
  • Materials For Medical Uses (AREA)
  • Application Of Or Painting With Fluid Materials (AREA)
AT97905309T 1996-02-29 1997-02-28 Bestimmung des kollagen genotyps ATE419380T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9604305.4A GB9604305D0 (en) 1996-02-29 1996-02-29 Diagnostic method and apparatus

Publications (1)

Publication Number Publication Date
ATE419380T1 true ATE419380T1 (de) 2009-01-15

Family

ID=10789624

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97905309T ATE419380T1 (de) 1996-02-29 1997-02-28 Bestimmung des kollagen genotyps

Country Status (9)

Country Link
US (1) US5922542A (de)
EP (1) EP0883694B1 (de)
AT (1) ATE419380T1 (de)
AU (1) AU718326B2 (de)
CA (1) CA2247171A1 (de)
DE (1) DE69739183D1 (de)
GB (1) GB9604305D0 (de)
NZ (1) NZ331489A (de)
WO (1) WO1997032041A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6407082B1 (en) * 1996-09-13 2002-06-18 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a vitamin D compound
US6034074A (en) 1996-09-13 2000-03-07 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a Vitamin D compound
US6765002B2 (en) 2000-03-21 2004-07-20 Gustavo Rodriguez Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
US6511970B1 (en) 1996-09-13 2003-01-28 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
US6028064A (en) 1996-09-13 2000-02-22 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of progestin products
US20010044431A1 (en) * 2000-03-21 2001-11-22 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
AU2002303827A1 (en) * 2001-05-25 2002-12-09 Invitrogen Corporation Compositions and methods for extension of nucleic acids
JP4174203B2 (ja) * 2001-10-11 2008-10-29 オキサゲン リミティッド 骨損傷の受け易さを判定する方法
GB2381526A (en) * 2001-11-03 2003-05-07 Sequenom Inc Detection of predisposition to osteoporosis
WO2003062465A1 (es) * 2002-01-25 2003-07-31 Universidad De Barcelona Compuestos para el diagnóstico de la predisposición a la osteoporosis
WO2008049953A1 (es) 2006-10-23 2008-05-02 Neocodex, S.L. Método de pronóstico y/o diagnóstico in vitro de hipersensibilidad a estrógenos o a sustancias con actividad estrogénica
CA2930693A1 (en) 2013-11-15 2015-05-21 The Board Of Trustees Of The Leland Stanford Junior Unversity Methods of treating heart failure with agonists of hypocretin receptor 2

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993011149A1 (en) * 1991-12-03 1993-06-10 Thomas Jefferson University Methods of detecting a genetic predisposition for osteoporosis
US5558988A (en) * 1992-11-13 1996-09-24 Thomas Jefferson University Primers and methods for detecting mutations in the procollagen II gene that indicate a genetic predisposition for osteoarthritis

Also Published As

Publication number Publication date
NZ331489A (en) 1999-10-28
WO1997032041A1 (en) 1997-09-04
US5922542A (en) 1999-07-13
AU2223597A (en) 1997-09-16
AU718326B2 (en) 2000-04-13
DE69739183D1 (de) 2009-02-12
EP0883694A1 (de) 1998-12-16
GB9604305D0 (en) 1996-05-01
CA2247171A1 (en) 1997-09-04
EP0883694B1 (de) 2008-12-31

Similar Documents

Publication Publication Date Title
DE69739183D1 (de) Bestimmung des kollagen genotyps
EA199700355A1 (ru) Метод диагностики шизофрении
FI953445A0 (fi) Menetelmä nukleiinihappojen herkkään osoitukseen
ATE224456T1 (de) Detektion einer genetischen prädisposition für diabetische retinopathie mit dem risiko des verlusts der sehkraft
DK1021722T3 (da) Forbedringer i eller relateret til screening for papillomavira
IL143748A0 (en) Substituted aryl or heteroarylamides having retinoid-like biological activity
FI875082A0 (fi) Dna-sekvensser deriverade fraon genom av papillomavirus, deras anvaendning foer in vitro diagnostiska aendamaol; samt framstaellning av antigeniska kompositioner.
DK0970240T3 (da) Kunstig fejlparringshydridisering
CY2406B1 (en) Assaying nucleotides in solution using pna probes.
BR0014150A (pt) Diagnósticos e terapêuticos para osteoporose
WO2000029623A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
CA2269664A1 (en) Diagnostic assay for breast cancer susceptibility
WO2003054166A3 (en) Nucleotide polymorphisms associated with osteoarthritis
ES2175095T3 (es) Marcadores de adn respecto al tamaño de una camada de cerdos.
ATE364717T1 (de) Diagnose durch bestimmung von polymorphismen in der promoterregion des tgf-beta 1 gens
NZ332702A (en) Diagnostic method and apparatus for detecting a predisposition to certain disease states, especially osteoporosis, based on polymorphism in an IL-6 gene
WO1996023880A3 (en) Novel allele of human histamine h2 receptor and methods of detection of h2 receptor variants
FR2678285B1 (de)
WO2002053018A3 (en) Method of detecting polymorphisms associated with breast carcinoma in mhc genes
AU2002214041A1 (en) Diagnosis of diseases associated with the human c-mos gene
WO2001077380A3 (en) Method for predicting predisposition to a disease associated with mutations in a rpgr gene
WO2001006005A3 (en) Diagnostic method comprising wt1 sequences
WO1998022586A3 (en) HUMAN POLYHOMEOTIC 2 (hph2) ACTS AS A TUMOR SUPPRESSOR
WO2000029622A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
WO2003054218A3 (en) Nucleotide polymorphisms associated with osteoporosis

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties